Page 97 - GTM-3-3

Global Translational Medicine SLE patient underwent PD

in such patients. Reports on treating patients diagnosed cohort study with more than 25 years of follow-up. Scand J
with both SLE and pancreatic cancer are extremely Rheumatol. 2018;47(6):461-464.
limited, and there is currently no established treatment doi: 10.1080/03009742.2017.1384054
strategy, though one is clearly needed. Further studies are Westermann R, Zobbe K, Cordtz R, Haugaard JH, Dreyer L.
required to determine the optimal treatment plan for this 3. Increased cancer risk in patients with cutaneous lupus
special group of patients who may be candidates for radical erythematosus and systemic lupus erythematosus compared
resection of pancreatic cancer. with the general population: A Danish nationwide cohort
study. Lupus. 2021;30(5):752-761.
Acknowledgments
doi: 10.1177/0961203321990106
We acknowledge the TCGA, GEO, and International
Cancer Genome Consortium databases, which were used 4. Seo MS, Yeo J, Hwang IC, Shim JY. Risk of pancreatic cancer
in patients with systemic lupus erythematosus: A meta-
in this manuscript, for providing their platforms and thank analysis. Clin Rheumatol. 2019;38(11):3109-3116.
the contributors who uploaded their meaningful datasets.
doi: 10.1007/s10067-019-04660-9
Funding 5. Huang SP, Guisinger A, Averell C, Bell CF, Rubin B. Clinical

The present study was supported by the National Natural and economic burden of systemic lupus erythematosus in
Science Foundation of China (82103570). the years preceding end-stage kidney disease diagnosis:
A retrospective observational study. Rheumatol Ther.
Conflict of interest 2023;10:551-562.
The authors declare that they have no conflict of interest. doi: 10.1007/s40744-023-00532-6
6. Au EH, Chapman JR, Craig JC, et al. Overall and site-
Author contributions specific cancer mortality in patients on dialysis and after
kidney transplant. J Am Soc Nephrol. 2019;30(3):471-480.
Conceptualization: Ran Wei, Xiaojun Lin, Bokang Cui
Formal analysis: Ran Wei, Dailei Qin, Zehui Yao doi: 10.1681/asn.2018090906
Methodology: Ran Wei, Dailei Qin 7. Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N,
Writing-original draft: Ran Wei, Dailei Qin Madeleine MM. Immunosuppressive medications and
Writing-review & editing: Xiaojun Lin, Bokang Cui squamous cell skin carcinoma: Nested case-control study
within the Skin Cancer after Organ Transplant (SCOT)
Ethics approval and consent to participate cohort. Am J Transplant. 2016;16(2):565-573.
Informed written patient consent was attained. All research doi: 10.1111/ajt.13596
was conducted in accordance with the Declaration of 8. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics
Helsinki. 2020: GLOBOCAN estimates of incidence and mortality
worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
Consent for publication 2021;71(3):209-249.
Informed written patient consent was attained to publish doi: 10.3322/caac.21660
this case.
9. Scarlett CJ, Salisbury EL, Biankin AV, Kench J. Precursor
Availability of data lesions in pancreatic cancer: Morphological and molecular
pathology. Pathology. 2011;43(3):183-200.
The sequencing data have been deposited in the NCBI doi: 10.1097/PAT.0b013e3283445e3a
sequence read archive database under the accession code
SUB13572385. The supporting data are available from the 10. Cancer Genome Atlas Research Network. Integrated genomic
corresponding author upon reasonable request. characterization of pancreatic ductal adenocarcinoma.
Cancer Cell. 2017;32(2):185-203.e13.
References doi: 10.1016/j.ccell.2017.07.007
1. Durcan L, O’Dwyer T, Petri M. Management strategies and 11. Rausch V, Krieg A, Camps J, et al. Array comparative genomic
future directions for systemic lupus erythematosus in adults. hybridization of 18 pancreatic ductal adenocarcinomas and
Lancet. 2019;393(10188):2332-2343. their autologous metastases. BMC Res Notes. 2017;10:560.
doi: 10.1016/s0140-6736(19)30237-5 doi: 10.1186/s13104-017-2886-0
2. Tallbacka KR, Pettersson T, Pukkala E. Increased incidence 12. Newman AM, Steen CB, Liu CL, et al. Determining cell type
of cancer in systemic lupus erythematosus: A Finnish abundance and expression from bulk tissues with digital

Volume 3 Issue 3 (2024) 6 doi: 10.36922/gtm.2893